Open AccessUse of Isoniazid Preventive Therapy for Tuberculosis Prophylaxis Among People Living With HIV/AIDS
Author(s) -
Melissa A. Briggs,
Courtney Emerson,
Surbhi Modi,
Nicholas Kenji Taylor,
Anand Date
Publication year - 2015
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000497
Subject(s) - medicine , tuberculosis , isoniazid , incidence (geometry) , human immunodeficiency virus (hiv) , antiretroviral therapy , pediatrics , family medicine , viral load , pathology , physics , optics
Tuberculosis (TB) is the leading preventable cause of death in persons living with HIV (PLHIV), accounting for over a quarter of all HIV-associated deaths in 2012. Isoniazid preventive therapy (IPT) has the potential to decrease TB-related cases and deaths in PLHIV; however, implementation of this has been slow in many high HIV- and TB-burden settings.